Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer

被引：12
|
作者：
Yamamoto, Shinya [1 ]
Kageyama, Yukio [2 ]
Fujii, Yasuhisa [1 ]
Aizawa, Taku [3 ]
Urakami, Shinji [1 ]
Fukui, Iwao [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan
[2] Saitama Canc Ctr, Dept Urol, Saitama, Japan
[3] Tokyo Med Univ, Dept Urol, Hachioji Med Ctr, Tokyo, Japan
来源：
ANTICANCER RESEARCH | 2020年 / 40卷 / 09期
关键词：
Single intravesical instillation; low-risk bladder cancer; pirarubicin; mitomycin C; TRANSURETHRAL RESECTION; INTERFERON-ALPHA; RECURRENCE; EPIRUBICIN; PROPHYLAXIS; TUMOR; CHEMOTHERAPY; MULTICENTER; PREVENTS; THIOTEPA;
D O I：
10.21873/anticanres.14535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: To assess the prophylactic efficacy of postoperative single intravesical instillation with pirarubicin (THP) and mitomycin C (MMC) for low-risk non-muscle-invasive bladder cancer (NMBC). Patients and Methods: A total of 103 clinically low-risk NMBC patients were preoperatively randomized into either THP (n=49) or MMC (n=54) groups. The primary endpoint was recurrence-free survival. Results: The median follow-up periods of the THP and MMC groups were 955 and 1008 days, respectively (p=0.76). Twelve patients (24 5%) in the THP group and 7 (13%) in the MMC group had bladder cancer recurrences. The two-year recurrence-free survival of the THP group and the MMC group was 77.8% and 86.4%, respectively (p=020). Neither groups had severe toxicity. Conclusion: In low-risk NMBC, the prophylactic effect against postoperative single intravesical instillation with THP was not superior to that with MMC.
引用
收藏
页码：5295 / 5299
页数：5
相关论文
共 50 条
  • [21] PROPHYLACTIC INTRAVESICAL INSTILLATION THERAPY WITH ADRIAMYCIN AND MITOMYCIN-C IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER
    TSUSHIMA, T
    MATSUMURA, Y
    OZAKI, Y
    YOSHIMOTO, J
    OHMORI, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 : S72 - S76
  • [22] Effectiveness of an Immediate Mitomycin C Instillation in Patients with Superficial Bladder Cancer Receiving Periodic Mitomycin C Instillation
    Jung, Seok Jin
    Chang, Hyuk Soo
    Park, Choal Hee
    Kim, Chun Il
    Kim, Byung Hoon
    KOREAN JOURNAL OF UROLOGY, 2011, 52 (05) : 323 - 326
  • [23] INTRAVESICAL MITOMYCIN-C INSTILLATION AS A PROPHYLACTIC TREATMENT OF SUPERFICIAL BLADDER-TUMOR
    KIM, HH
    LEE, CW
    JOURNAL OF UROLOGY, 1989, 141 (06): : 1337 - 1340
  • [24] Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer:: Short and long-term followup
    Solsona, E
    Iborra, I
    Ricós, JV
    Monrós, JL
    Casanova, J
    Dumont, R
    JOURNAL OF UROLOGY, 1999, 161 (04): : 1120 - 1123
  • [25] Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: Long-term results
    Hurle, R
    Manzetti, A
    Losa, A
    Micheli, E
    Ranieri, A
    Chinaglia, D
    Lembo, A
    UROLOGIA INTERNATIONALIS, 1998, 61 (04) : 220 - 226
  • [26] Audit of Instillation of Intravesical Mitomycin-C Following Transurethral Resection for Bladder Tumour
    McCabe, G.
    Sahni, D. S.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [27] NEOADJUVANT SHORT-TERM INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN COMPARED TO STANDARD SCHEDULE FOR LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER. A RANDOMIZED PHASE II STUDY
    Rocchini, Lorenzo
    Suardi, Nazareno
    Federico, Pellucchi
    Maccagnano, Carmen
    Fabio, Benigni
    Giorgia, Colciago
    Arianna, Bettiga
    Patrizio, Rigatti
    Montorsi, Francesco
    Colombo, Renzo
    JOURNAL OF UROLOGY, 2012, 187 (04): : E714 - E715
  • [28] POSTOPERATIVE PROPHYLACTIC INTRAVESICAL INSTILLATION OF CYTOSINE-ARABINOSIDE AND MITOMYCIN-C IN SUPERFICIAL BLADDER-TUMOR - A FOLLOW-UP-STUDY
    OMOTO, T
    KANO, M
    ARIYOSHI, A
    MOMOSE, S
    MASAKI, Z
    MORITA, I
    ISHISAWA, N
    UROLOGY, 1982, 20 (05) : 510 - 514
  • [29] Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer
    Oosterlinck, Willem
    Decaestecker, Karel
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S135 - S137
  • [30] The value of transurethral thulium laser en bloc resection combined with a single immediate postoperative intravesical instillation of pirarubicin in primary non-muscle-invasive bladder cancer
    Sheng Xu
    Shaoying Tan
    Tingming Wu
    Jun Gu
    Lei Xu
    Xianping Che
    Lasers in Medical Science, 2020, 35 : 1695 - 1701
12345